Atai Life Sciences EBITDA Margin 2020-2025 | ATAI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Atai Life Sciences (ATAI) over the last 10 years. The current EBITDA margin for Atai Life Sciences as of March 31, 2025 is .
| Atai Life Sciences EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2025-03-31 |
$0.00B |
$-0.10B |
-4950.00% |
| 2024-09-30 |
$0.00B |
$-0.11B |
0.00% |
| 2024-06-30 |
$0.00B |
$-0.11B |
0.00% |
| 2023-12-31 |
$0.00B |
$-0.13B |
0.00% |
| 2023-09-30 |
$0.00B |
$-0.13B |
0.00% |
| 2023-06-30 |
$0.00B |
$-0.14B |
0.00% |
| 2023-03-31 |
$0.00B |
$-0.14B |
0.00% |
| 2022-09-30 |
$0.00B |
$-0.15B |
0.00% |
| 2022-06-30 |
$0.00B |
$-0.15B |
0.00% |
| 2021-12-31 |
$0.02B |
$-0.14B |
-675.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.527B |
$0.000B |
|
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|
